HVEM gene expression is proposed to be a promising prognostic marker in metastatic melanomas when expressed on melanoma cells to interact with BTLA on tumor-infiltrating lymphocytes (TILs) [11]. This evidence concerns the gene TNFRSF14 and melanoma.